{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:04:37Z","timestamp":1789635877261,"version":"4.0.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100005258","name":"National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention","doi-asserted-by":"publisher","award":["5NU62PS924771"],"award-info":[{"award-number":["5NU62PS924771"]}],"id":[{"id":"10.13039\/100005258","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10461-026-05072-y","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T07:19:20Z","timestamp":1772090360000},"page":"2670-2687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Trends in HCV Prevalence and Risk Factors Among People who Inject Drugs in Los Angeles County, 2012\u20132024"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7898-6533","authenticated-orcid":false,"given":"Yingbo","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6373-8358","authenticated-orcid":false,"given":"Ekow Kwa","family":"Sey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Santacruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3209-176X","authenticated-orcid":false,"given":"Jennifer","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4014-3703","authenticated-orcid":false,"given":"Siri","family":"Chirumamilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"5072_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1093\/cid\/cis393","volume":"55","author":"RM Klevens","year":"2012","unstructured":"Klevens RM, Hu DJ, Jiles R, Holmberg SD. Evolving epidemiology of hepatitis C virus in the united States. Clin Infect Dis. 2012;55:S3\u20139. https:\/\/doi.org\/10.1093\/cid\/cis393.","journal-title":"Clin Infect Dis"},{"key":"5072_CR2","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/j.1360-0443.2011.03765.x","volume":"107","author":"ER Pouget","year":"2012","unstructured":"Pouget ER, Hagan H, Des Jarlais DC. <article-title update=\"added\">Meta\u2010analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. Addiction. 2012;107:1057\u201365. https:\/\/doi.org\/10.1111\/j.1360-0443.2011.03765.x.","journal-title":"Addiction"},{"key":"5072_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104387","volume":"144","author":"J Chapin-Bardales","year":"2025","unstructured":"Chapin-Bardales J, Asher A, Broz D, Teshale E, Mixson-Hayden T, Poe A, et al. Hepatitis C virus infection and co-infection with HIV among persons who inject drugs in 10 U.S. cities\u2014National HIV behavioral surveillance, 2018. Int J Drug Policy. 2025;144:104387. https:\/\/doi.org\/10.1016\/j.drugpo.2024.104387.","journal-title":"Int J Drug Policy"},{"key":"5072_CR4","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1053\/jhep.2001.29201","volume":"34","author":"V Di Martino","year":"2001","unstructured":"Di Martino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M, et al. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology. 2001;34:1193\u20139. https:\/\/doi.org\/10.1053\/jhep.2001.29201.","journal-title":"Hepatology"},{"key":"5072_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad319","author":"D Bhattacharya","year":"2023","unstructured":"Bhattacharya D, Aronsohn A, Price J, Lo Re V, the American Association for the Study of Liver Diseases\u2013Infectious Diseases Society of America HCV Guidance Panel, Heald J, et al. Hepatitis C guidance 2023 update: American association for the study of liver diseases\u2013 infectious diseases society of America recommendations for Testing, Managing, and treating hepatitis C virus infection. Clin Infect Dis. 2023. https:\/\/doi.org\/10.1093\/cid\/ciad319. ciad319.","journal-title":"Clin Infect Dis"},{"key":"5072_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S2468-1253(24)00442-4","volume":"10","author":"A Artenie","year":"2025","unstructured":"Artenie A, Trickey A, Looker KJ, Stone J, Lim AG, Fraser H, et al. Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysis. The Lancet Gastroenterology & Hepatology. 2025;10:315\u201331. https:\/\/doi.org\/10.1016\/S2468-1253(24)00442-4.","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"5072_CR7","unstructured":"Centers for Disease Control and Prevention. Viral Hepatitis Surveillance Report \u2013 United States. 2023. [Internet]. https:\/\/www.cdc.gov\/hepatitis-surveillance-2023\/about\/index.html Published April 2025."},{"key":"5072_CR8","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/HEP.0000000000000927","volume":"81","author":"EW Hall","year":"2025","unstructured":"Hall EW, Bradley H, Barker LK, Lewis KC, Shealey J, Valverde E, et al. Estimating hepatitis C prevalence in the united States, 2017\u20132020. Hepatology. 2025;81:625\u201336. https:\/\/doi.org\/10.1097\/HEP.0000000000000927.","journal-title":"Hepatology"},{"key":"5072_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.6371","volume":"1","author":"ES Rosenberg","year":"2018","unstructured":"Rosenberg ES, Rosenthal EM, Hall EW, Barker L, Hofmeister MG, Sullivan PS, et al. Prevalence of hepatitis C virus infection in US states and the district of Columbia, 2013 to 2016. JAMA Netw Open. 2018;1:e186371. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.6371.","journal-title":"JAMA Netw Open"},{"issue":"10","key":"5072_CR10","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/jama.2020.1123","volume":"323","author":"DK Owens","year":"2020","unstructured":"Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, et al. Screening for hepatitis C virus infection in adolescents and adults: US preventive services task force recommendation statement. JAMA. 2020;323:970. https:\/\/doi.org\/10.1001\/jama.2020.1123.","journal-title":"JAMA"},{"issue":"11","key":"5072_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.70087","volume":"32","author":"MG Ghany","year":"2025","unstructured":"Ghany MG, Ward JW, Baldwin Z, Jiao S, Shukla N, Kuznetsova A, Kaur J, Kosch KJ, Morgan TR. HCV Testing and treatment of adults in the United States: 2014 through 2021-data from two national commercial testing laboratories. J Viral Hepat. 2025;32(11): e70087. https:\/\/doi.org\/10.1111\/jvh.70087.","journal-title":"J Viral Hepat"},{"key":"5072_CR12","doi-asserted-by":"publisher","first-page":"766","DOI":"10.15585\/mmwr.mm7228a2","volume":"72","author":"EJ Cartwright","year":"2023","unstructured":"Cartwright EJ, Patel P, Kamili S, Wester C. Updated operational guidance for implementing CDC\u2019s recommendations on testing for hepatitis C virus infection. MMWR Morb Mortal Wkly Rep. 2023;72:766\u20138. https:\/\/doi.org\/10.15585\/mmwr.mm7228a2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5072_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/infdis\/jiz142","volume":"220","author":"WE Abara","year":"2019","unstructured":"Abara WE, Trujillo L, Broz D, Finlayson T, Teshale E, Paz-Bailey G, et al. Age-related differences in past or present hepatitis C virus infection among people who inject drugs: national human immunodeficiency virus behavioral surveillance, 8 US cities, 2015. J Infect Dis. 2019;220:377\u201385. https:\/\/doi.org\/10.1093\/infdis\/jiz142.","journal-title":"J Infect Dis"},{"key":"5072_CR14","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1007\/s10900-015-0016-2","volume":"40","author":"M Schulte","year":"2015","unstructured":"Schulte M, Hser Y, Saxon A, Evans E, Li L, Huang D, et al. Risk factors associated with HCV among opioid-dependent patients in a multisite study. J Community Health. 2015;40:940\u20137. https:\/\/doi.org\/10.1007\/s10900-015-0016-2.","journal-title":"J Community Health"},{"key":"5072_CR15","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1086\/649783","volume":"201","author":"H Hagan","year":"2010","unstructured":"Hagan H, Pouget ER, Williams IT, Garfein RL, Strathdee SA, Hudson SM, et al. Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. J Infect Dis. 2010;201:378\u201385. https:\/\/doi.org\/10.1086\/649783.","journal-title":"J Infect Dis"},{"key":"5072_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/infdis\/jir196","volume":"204","author":"H Hagan","year":"2011","unstructured":"Hagan H, Pouget ER, Des Jarlais DC. A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. J Infect Dis. 2011;204:74\u201383. https:\/\/doi.org\/10.1093\/infdis\/jir196.","journal-title":"J Infect Dis"},{"key":"5072_CR17","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/hep.26387","volume":"58","author":"S Larney","year":"2013","unstructured":"Larney S, Kopinski H, Beckwith CG, Zaller ND, Jarlais DD, Hagan H, et al. Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology. 2013;58:1215\u201324. https:\/\/doi.org\/10.1002\/hep.26387.","journal-title":"Hepatology"},{"key":"5072_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11904-019-00476-z","volume":"17","author":"S Ocal","year":"2020","unstructured":"Ocal S, Muir AJ. Addressing hepatitis C in the American incarcerated population: strategies for nationwide elimination. Curr HIV AIDS Rep. 2020;17:18\u201325. https:\/\/doi.org\/10.1007\/s11904-019-00476-z.","journal-title":"Curr HIV AIDS Rep"},{"key":"5072_CR19","doi-asserted-by":"publisher","unstructured":"Chandra Deb L, Hove H, Miller TK, Pinks K, Njau G, Hagan JJ et al. Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota. Huang J-F, editor. PLoS ONE. 2022;17:e0266047. https:\/\/doi.org\/10.1371\/journal.pone.0266047","DOI":"10.1371\/journal.pone.0266047"},{"key":"5072_CR20","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S2468-1253(23)00018-3","volume":"8","author":"A Artenie","year":"2023","unstructured":"Artenie A, Stone J, Fraser H, Stewart D, Arum C, Lim AG, et al. Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. 2023;8:533\u201352. https:\/\/doi.org\/10.1016\/S2468-1253(23)00018-3.","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"5072_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/jvh.12628","volume":"24","author":"A Esmaeili","year":"2017","unstructured":"Esmaeili A, Mirzazadeh A, Carter GM, Esmaeili A, Hajarizadeh B, Sacks HS, et al. Higher incidence of HCV in females compared to males who inject drugs: A systematic review and meta-analysis. J Viral Hepatitis. 2017;24:117\u201327. https:\/\/doi.org\/10.1111\/jvh.12628.","journal-title":"J Viral Hepatitis"},{"key":"5072_CR22","doi-asserted-by":"publisher","first-page":"949","DOI":"10.2105\/AJPH.2020.306149","volume":"111","author":"D Holtzman","year":"2021","unstructured":"Holtzman D, Asher AK, Schillie S. The changing epidemiology of hepatitis C virus infection in the United States during the years 2010 to 2018. Am J Public Health. 2021;111:949\u201355. https:\/\/doi.org\/10.2105\/AJPH.2020.306149.","journal-title":"Am J Public Health"},{"key":"5072_CR23","doi-asserted-by":"publisher","first-page":"e2324770","DOI":"10.1001\/jamanetworkopen.2023.24770","volume":"6","author":"P-H Chen","year":"2023","unstructured":"Chen P-H, Johnson L, Limketkai BN, Jusuf E, Sun J, Kim B, et al. Trends in the prevalence of hepatitis C infection during pregnancy and maternal-infant outcomes in the US, 1998 to 2018. JAMA Netw Open. 2023;6:e2324770\u2013e2324770. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.24770.","journal-title":"JAMA Netw Open"},{"key":"5072_CR24","unstructured":"Los Angeles County Acute Communicable Disease Control Disease Surveillance Data Dashboard. Annual morbidities for select reportable acute communicable diseases [Internet]. http:\/\/dashboard.publichealth.lacounty.gov\/acdc_annual_report_dashboard\/"},{"key":"5072_CR25","unstructured":"California Department of Public Health. Directory of Syringe Services Programs in California [Internet]. [cited 2025 Jan 1]. https:\/\/www.cdph.ca.gov\/Programs\/CID\/DOA\/pages\/oa_prev_sepdirectory.aspx. Accessed 1 Jan 2025."},{"key":"5072_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2024.111419","volume":"263","author":"G Karandinos","year":"2024","unstructured":"Karandinos G, Unick J, Ondocsin J, Holm N, Mars S, Montero F, et al. Decrease in injection and rise in smoking and snorting of heroin and synthetic opioids, 2000\u20132021. Drug Alcohol Depend. 2024;263:111419. https:\/\/doi.org\/10.1016\/j.drugalcdep.2024.111419.","journal-title":"Drug Alcohol Depend"},{"key":"5072_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2024.100317","volume":"14","author":"EO Chung","year":"2025","unstructured":"Chung EO, Patel SV, Wenger LD, Humphrey JL, Sukasih A, Bluthenthal RN, et al. Association of safer smoking supply distribution with participant encounters and naloxone distribution from syringe services programs: findings from the National Survey of Syringe Services Programs in the United States. Drug and Alcohol Dependence Reports. 2025;14:100317. https:\/\/doi.org\/10.1016\/j.dadr.2024.100317.","journal-title":"Drug and Alcohol Dependence Reports"},{"key":"5072_CR28","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/add.14012","volume":"113","author":"L Platt","year":"2018","unstructured":"Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, et al. Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis. Addiction. 2018;113:545\u201363. https:\/\/doi.org\/10.1111\/add.14012.","journal-title":"Addiction"},{"key":"5072_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-017-4210-2","volume":"17","author":"RM Fernandes","year":"2017","unstructured":"Fernandes RM, Cary M, Duarte G, Jesus G, Alarc\u00e3o J, Torre C, et al. Effectiveness of needle and syringe programmes in people who inject drugs \u2013 an overview of systematic reviews. BMC Public Health. 2017;17:309. https:\/\/doi.org\/10.1186\/s12889-017-4210-2.","journal-title":"BMC Public Health"},{"key":"5072_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-022-00358-7","volume":"18","author":"E Romo","year":"2023","unstructured":"Romo E, Rudolph AE, Stopka TJ, Wang B, Jesdale BM, Friedmann PD. HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England. Addict Sci Clin Pract. 2023;18:2. https:\/\/doi.org\/10.1186\/s13722-022-00358-7.","journal-title":"Addict Sci Clin Pract"},{"key":"5072_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.drugalcdep.2019.04.025","volume":"202","author":"H Levine","year":"2019","unstructured":"Levine H, Bartholomew TS, Rea-Wilson V, Onugha J, Arriola DJ, Cardenas G, et al. Syringe disposal among people who inject drugs before and after the implementation of a syringe services program. Drug Alcohol Depend. 2019;202:13\u20137. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.04.025.","journal-title":"Drug Alcohol Depend"},{"key":"5072_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0740-5472(00)00104-5","volume":"19","author":"H Hagan","year":"2000","unstructured":"Hagan H, McGough JP, Thiede H, Hopkins S, Duchin J, Alexander ER. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. J Subst Abuse Treat. 2000;19:247\u201352. https:\/\/doi.org\/10.1016\/S0740-5472(00)00104-5.","journal-title":"J Subst Abuse Treat"},{"key":"5072_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00126334-200306010-00014","volume":"33","author":"DG Fisher","year":"2003","unstructured":"Fisher DG, Fenaughty AM, Cagle HH, Wells RS. Needle exchange and injection drug use frequency: a randomized clinical trial: JAIDS Journal of Acquired Immune Deficiency Syndromes. JAIDS J Acquir Immune Defic Syndr. 2003;33:199\u2013205. https:\/\/doi.org\/10.1097\/00126334-200306010-00014.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"5072_CR34","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.2105\/AJPH.90.12.1933","volume":"90","author":"Trends in crime","year":"2000","unstructured":"Trends in crime. And the introduction of a needle exchange program. Am J Public Health. 2000;90:1933\u20136. https:\/\/doi.org\/10.2105\/AJPH.90.12.1933.","journal-title":"Am J Public Health"},{"key":"5072_CR35","unstructured":"Los Angeles County Department of Public Health Acute Communicable Disease Control. 2023 viral hepatitis surveillance report [Internet]. http:\/\/ph.lacounty.gov\/acd\/diseases\/hepatitis\/docs\/ViralHepatitis2023AnnualReport.pdf"},{"issue":"Suppl 1","key":"5072_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/00333549071220S106","volume":"122","author":"KM Gallagher","year":"2007","unstructured":"Gallagher KM, Sullivan PS, Lansky A, Onorato IM. Behavioral surveillance among people at risk for HIV infection in the U.S.: the National HIV behavioral surveillance system. Public Health Rep. 2007;122(Suppl 1):32\u20138. https:\/\/doi.org\/10.1177\/00333549071220S106.","journal-title":"Public Health Rep"},{"issue":"12","key":"5072_CR37","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1007\/s10461-019-02605-6","volume":"23","author":"A Scheim","year":"2019","unstructured":"Scheim A, Knight R, Shulha H, Nosova E, Hayashi K, Milloy MJ, Kerr T, DeBeck K. Characterizing men who have sex with men and use injection drugs in Vancouver, Canada. AIDS Behav. 2019;23(12):3324\u201330. https:\/\/doi.org\/10.1007\/s10461-019-02605-6.","journal-title":"AIDS Behav"},{"issue":"4","key":"5072_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.704","volume":"5","author":"A Artenie","year":"2022","unstructured":"Artenie A, Facente SN, Patel S, Stone J, Hecht J, Rhodes P, et al. A cross-sectional study comparing men who have sex with men and inject drugs and people who inject drugs who are men and have sex with men in San Francisco: implications for HIV and hepatitis C virus prevention. Health Sci Rep. 2022;5(4):e704. https:\/\/doi.org\/10.1002\/hsr2.704.","journal-title":"Health Sci Rep"},{"key":"5072_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-019-0842-5","volume":"19","author":"L Avery","year":"2019","unstructured":"Avery L, Rotondi N, McKnight C, Firestone M, Smylie J, Rotondi M. Unweighted regression models perform better than weighted regression techniques for respondent-driven sampling data: results from a simulation study. BMC Med Res Methodol. 2019;19:202. https:\/\/doi.org\/10.1186\/s12874-019-0842-5.","journal-title":"BMC Med Res Methodol"},{"key":"5072_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.835836","volume":"10","author":"P Mateu-Gelabert","year":"2022","unstructured":"Mateu-Gelabert P, Sabounchi NS, Guarino H, Ciervo C, Joseph K, Eckhardt BJ, et al. Hepatitis C virus risk among young people who inject drugs. Front Public Health. 2022;10:835836. https:\/\/doi.org\/10.3389\/fpubh.2022.835836.","journal-title":"Front Public Health"},{"key":"5072_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.2211","volume":"7","author":"M-G Pedro","year":"2024","unstructured":"Pedro M-G, Seanna P, Honoria G, Renee H, Chunki F, Ben E. HCV prevalence and phylogenetic characteristics in a cross-sectional, community study of young people who inject drugs in New York City: opportunity for and threats to HCV elimination. Health Sci Rep. 2024;7:e2211. https:\/\/doi.org\/10.1002\/hsr2.2211.","journal-title":"Health Sci Rep"},{"key":"5072_CR42","unstructured":"Division of HIV and STD Programs, Department of Public Health, County of Los Angeles. HIV Surveillance Annual Report, 2023. Published December 2, 2024. https:\/\/publichealth.lacounty.gov\/dhsp\/Reports\/HIV\/2023AnnualHIVSurveillanceReport.pdf"},{"key":"5072_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108797","volume":"225","author":"A Hotton","year":"2021","unstructured":"Hotton A, Mackesy-Amiti M-E, Boodram B. Trends in homelessness and injection practices among young urban and suburban people who inject drugs: 1997\u20132017. Drug Alcohol Depend. 2021;225:108797. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108797.","journal-title":"Drug Alcohol Depend"},{"key":"5072_CR44","doi-asserted-by":"publisher","first-page":"S401","DOI":"10.1093\/infdis\/jiaa238","volume":"222","author":"M Adams","year":"2020","unstructured":"Adams M, Sionean C, Broz D, Lewis R, Wejnert C, NHBS Study Group. Serious mental illness among young people who inject drugs: an assessment of injection risks and healthcare use. J Infect Dis. 2020;222:S401\u20139. https:\/\/doi.org\/10.1093\/infdis\/jiaa238.","journal-title":"J Infect Dis"},{"key":"5072_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-025-01236-6","volume":"22","author":"A Zhang","year":"2025","unstructured":"Zhang A, Carrillo M, Liu R, et al. Vending machines for reducing harm associated with substance use and use disorders, and co-occurring conditions: a systematic review. Harm Reduct J. 2025;22:89. https:\/\/doi.org\/10.1186\/s12954-025-01236-6.","journal-title":"Harm Reduct J"},{"key":"5072_CR46","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1080\/17450128.2024.2390593","volume":"19","author":"I S\u00f6nmez","year":"2024","unstructured":"S\u00f6nmez I, Espelt A, Maj\u00f3 X, Bartroli M, Mero\u00f1o M, Gonz\u00e1lez V, et al. Trends in the prevalence of HIV, HCV, and co-infection and associated factors among young people who inject drugs (PWID) in Catalonia (2008\u20132019). Vulnerable Child Youth Stud. 2024;19:661\u201375. https:\/\/doi.org\/10.1080\/17450128.2024.2390593.","journal-title":"Vulnerable Child Youth Stud"},{"key":"5072_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102596","volume":"72","author":"A Levinsson","year":"2024","unstructured":"Levinsson A, Zolopa C, Vakili F, Udhesister S, Kronfli N, Maheu-Giroux M, et al. Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis. eClinicalMedicine. 2024;72:102596. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102596.","journal-title":"eClinicalMedicine"},{"issue":"11","key":"5072_CR48","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1177\/10497323211021782","volume":"31","author":"AM Nyamathi","year":"2021","unstructured":"Nyamathi AM, Wall SA, Yadav K, et al. Engaging the community in designing a hepatitis C virus treatment program for adults experiencing homelessness. Qual Health Res. 2021;31(11):2069\u201383. https:\/\/doi.org\/10.1177\/10497323211021782.","journal-title":"Qual Health Res"},{"key":"5072_CR49","unstructured":"Downtown Women\u2019s Center (DWC).About. Downtown Women\u2019s Center. [Internet]. [cited 2025 Dec 10]. https:\/\/downtownwomenscenter.org\/about\/. Accessed 10 Dec 2025."},{"key":"5072_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104433","volume":"128","author":"C Gahrton","year":"2024","unstructured":"Gahrton C, Nav\u00e9r G, Warnqvist A, Dalgard O, Aleman S, K\u00e5berg M. Changes in hepatitis C virus prevalence and incidence among people who inject drugs in the direct acting antiviral era. Int J Drug Policy. 2024;128:104433. https:\/\/doi.org\/10.1016\/j.drugpo.2024.104433.","journal-title":"Int J Drug Policy"},{"key":"5072_CR51","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","volume":"34","author":"D Ciccarone","year":"2021","unstructured":"Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry. 2021;34:344\u201350. https:\/\/doi.org\/10.1097\/YCO.0000000000000717.","journal-title":"Curr Opin Psychiatry"},{"key":"5072_CR52","unstructured":"Millennium Health Signals Report\u2122 Volume 6. The Fourth Wave\u2013 The Rise of Stimulants and the Evolution of Polysubstance Use in America\u2019s Fentanyl Crisis [Internet]. https:\/\/resource.millenniumhealth.com\/signalsreportvol6"},{"key":"5072_CR53","unstructured":"Substance Abuse prevention and Control, Department of Public Health., County of Los Angeles. Data Brief Methamphetamine Misuse\/ Abuse and Consequences [Internet]. http:\/\/publichealth.lacounty.gov\/sapc\/MDU\/MDBrief\/MethBrief.pdf"},{"key":"5072_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2023.100176","volume":"8","author":"LM Benrubi","year":"2023","unstructured":"Benrubi LM, Silcox J, Hughto J, Stopka TJ, Palacios WR, Shrestha S, et al. Trends and correlates of abscess history among people who inject drugs in Massachusetts: a mixed methods exploration of experiences amidst a rapidly evolving drug supply. Drug Alcohol Depend Rep. 2023;8:100176. https:\/\/doi.org\/10.1016\/j.dadr.2023.100176.","journal-title":"Drug Alcohol Depend Rep"},{"key":"5072_CR55","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s10461-022-03832-0","volume":"27","author":"AE Rudolph","year":"2023","unstructured":"Rudolph AE, Rhodes SE. Network correlates of using a syringe after an injection partner among women who inject drugs in Philadelphia Pennsylvania. AIDS Behav. 2023;27:957\u201368. https:\/\/doi.org\/10.1007\/s10461-022-03832-0.","journal-title":"AIDS Behav"},{"key":"5072_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104222","volume":"141","author":"AT Estadt","year":"2025","unstructured":"Estadt AT, Miller WC, Kline D, Whitney BM, Young AM, Korthuis PT, et al. Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities. Int J Drug Policy. 2025;141:104222. https:\/\/doi.org\/10.1016\/j.drugpo.2023.104222.","journal-title":"Int J Drug Policy"},{"key":"5072_CR57","unstructured":"CDC. Viral Hepatitis Surveillance Report \u2013 United States, 2022 [Internet]. 2024. https:\/\/www.cdc.gov\/hepatitis-surveillance-2022\/about\/index.html"},{"key":"5072_CR58","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11524-018-0277-z","volume":"95","author":"AG Wurcel","year":"2018","unstructured":"Wurcel AG, Burke DJ, Wang JJ, Engle B, Noonan K, Knox TA, et al. The burden of untreated HCV infection in hospitalized inmates: a hospital utilization and cost analysis. J Urban Health. 2018;95:467\u201373. https:\/\/doi.org\/10.1007\/s11524-018-0277-z.","journal-title":"J Urban Health"},{"issue":"2","key":"5072_CR59","doi-asserted-by":"publisher","first-page":"77","DOI":"10.18176\/resp.00109","volume":"27","author":"R Baptista-Leite","year":"2025","unstructured":"Baptista-Leite R, Lopes H, Franco D, Clemens T, Brand H. Using time in prison as an ideal opportunity to treat hepatitis C - PIONEER framework proposal. Rev Esp Sanid Penit. 2025;27(2):77\u201387. https:\/\/doi.org\/10.18176\/resp.00109.","journal-title":"Rev Esp Sanid Penit"},{"key":"5072_CR60","unstructured":"Wolchok LL, Angeles County Department of Health Services Correctional Health Services. Hepatitis C Care in Los Angles County Jails [Internet]. 2019. https:\/\/www.hhs.gov\/sites\/default\/files\/Hepatitis-C-Care-in-Los-Angeles-County-Jails-2019.pdf"},{"issue":"5","key":"5072_CR61","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/add.14971","volume":"115","author":"NK Martin","year":"2020","unstructured":"Martin NK, Hickman M, Spaulding AC, Vickerman P. Prisons can also improve drug user health in the community. Addiction. 2020;115(5):914\u20135. https:\/\/doi.org\/10.1111\/add.14971.","journal-title":"Addiction"},{"key":"5072_CR62","unstructured":"2023 STD Surveillance Snapshot. [Internet]. Division of HIV and STD Programs, Los Angeles County Department of Public Health.; http:\/\/publichealth.lacounty.gov\/dhsp\/Reports.htm. Published January 2025."},{"key":"5072_CR63","doi-asserted-by":"publisher","first-page":"ofae107","DOI":"10.1093\/ofid\/ofae107","volume":"11","author":"LA Gonzalez Corro","year":"2024","unstructured":"Gonzalez Corro LA, Zook K, Landry M, Rosecrans A, Harris R, Gaskin D, et al. An analysis of social determinants of health and their implications for hepatitis C virus treatment in people who inject drugs: the case of Baltimore. Open Forum Infect Dis. 2024;11:ofae107. https:\/\/doi.org\/10.1093\/ofid\/ofae107.","journal-title":"Open Forum Infect Dis"},{"key":"5072_CR64","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1465-3362.2010.00188.x","volume":"30","author":"J Macneil","year":"2011","unstructured":"Macneil J, Pauly B. Needle exchange as a safe Haven in an unsafe world: needle exchange as a safe Haven. Drug Alcohol Rev. 2011;30:26\u201332. https:\/\/doi.org\/10.1111\/j.1465-3362.2010.00188.x.","journal-title":"Drug Alcohol Rev"},{"key":"5072_CR65","doi-asserted-by":"publisher","DOI":"10.1097\/PHH.0000000000002139","author":"C Stafylis","year":"2025","unstructured":"Stafylis C, Hernandez-Tamayo C, Bhardwaj L, Shah R, Becerra T, Bruce D, et al. Project HCV connect: using a County surveillance registry to link hepatitis C virus-infected residents to cure\u2014Los Angeles County, April 2023 to March 2024. J Public Health Manag Pract. 2025. https:\/\/doi.org\/10.1097\/PHH.0000000000002139.","journal-title":"J Public Health Manag Pract"},{"key":"5072_CR66","doi-asserted-by":"publisher","first-page":"716","DOI":"10.15585\/mmwr.mm7226a3","volume":"72","author":"C Wester","year":"2023","unstructured":"Wester C, Osinubi A, Kaufman HW, et al. Hepatitis C virus clearance Cascade \u2014 United States, 2013\u20132022. MMWR Morb Mortal Wkly Rep. 2023;72:716\u201320. https:\/\/doi.org\/10.15585\/mmwr.mm7226a3.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5072_CR67","volume-title":"Viral hepatitis National strategic plan for the united states: a roadmap to elimination for the united States, 2021\u20132025","author":"US Department of Health and Human Services","year":"2020","unstructured":"US Department of Health and Human Services. Viral hepatitis National strategic plan for the united states: a roadmap to elimination for the united States, 2021\u20132025. Washington, DC: US Department of Health and Human Services; 2020. https:\/\/www.hhs.gov\/sites\/default\/files\/Viral-Hepatitis-National-Strategic. -Plan-2021-2025.pdf."},{"key":"5072_CR68","doi-asserted-by":"publisher","first-page":"ofad125","DOI":"10.1093\/ofid\/ofad125","volume":"10","author":"C Hernandez-Tamayo","year":"2023","unstructured":"Hernandez-Tamayo C, Stafylis C, Klausner JD. Lack of hepatitis C virus elimination by 2030 in Los Angeles County at current treatment rate. Open Forum Infect Dis United States. 2023;10:ofad125. https:\/\/doi.org\/10.1093\/ofid\/ofad125.","journal-title":"Open Forum Infect Dis United States"},{"key":"5072_CR69","doi-asserted-by":"publisher","first-page":"660","DOI":"10.15585\/mmwr.mm7330a1","volume":"73","author":"RA Tohme","year":"2024","unstructured":"Tohme RA, Shadaker S, Adamia E, et al. Progress toward the elimination of hepatitis B and hepatitis C in the country of Georgia, April 2015\u2013April 2024. MMWR Morb Mortal Wkly Rep. 2024;73:660\u20136. https:\/\/doi.org\/10.15585\/mmwr.mm7330a1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5072_CR70","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12879-021-05920-3","volume":"21","author":"I Kamali","year":"2021","unstructured":"Kamali I, Barnhart DA, Nyirahabihirwe F, et al. Initiation of hepatitis C treatment in two rural Rwandan districts: a mobile clinic approach. BMC Infect Dis. 2021;21:220.","journal-title":"BMC Infect Dis"},{"key":"5072_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2023.100213","author":"JI Tsui","year":"2023","unstructured":"Tsui JI, Gojic AJ, Pierce KA, et al. Pilot study of a community pharmacist led program to treat hepatitis C virus among people who inject drugs. Drug Alcohol Depend Rep. 2023. https:\/\/doi.org\/10.1016\/j.dadr.2023.100213.","journal-title":"Drug Alcohol Depend Rep."}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05072-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-026-05072-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05072-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:35:48Z","timestamp":1789634148000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-026-05072-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":71,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5072"],"URL":"https:\/\/doi.org\/10.1007\/s10461-026-05072-y","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"4 February 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}